Fundraising Fox

Gimv

Growth equity

Antwerp · Growth–Late Stage · 11 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Gimv invests in innovation and entrepreneurship, backing entrepreneurial and innovative companies through four strategic investment platforms shaped by societal trends: digitalisation & automation, electrification & energy efficiency, sustainable food & wellbeing, and healthcare. Its approach is built on a solid balance sheet, patient capital and a long-term view, aiming for sustainable value creation by partnering closely with ambitious management teams. As a recognized European market leader, Gimv manages a portfolio of around 60 companies representing roughly EUR 5 billion in combined turnover and more than 20,000 employees.

Source: firm website, verified Aug 3, 2026.

Stage
Growth–Late Stage
Check
$21M – $430M
HQ
Antwerp, BE
Leads rounds
Leads
Instruments
Equity
Founded
1980
Last 12 months
1 investment
Tracked investments
9

Team · 11 people

from public directories

What they invest in

from 6 of 9 portfolio companies

Biotech ×4Healthtech ×3Medical Devices ×2Advanced Manufacturing ×1Energy ×1Hardware ×1Mobility & Transportation ×1

HQs:Germany×2Netherlands×1United States×1

Investments · 9 tracked

founders shown can be your intro path
Topas Therapeuticstopas-therapeutics.comin✓ verified

Topas Therapeutics develops nanoparticle-based therapies to induce immune tolerance for autoimmune and immune-mediated diseases.

BiotechHealthtech

Hugo Fry(Chief Executive Officer)Christian Schröter(Chief Operating Officer)Cristina de Min(Chief Medical Officer)Anne Burger(Chief Financial Officer)Alex Marshall(Chief Business Officer)

Co-investorsEMBL VenturesBoehringer Ingelheim Venture FundBioMedPartnersEpidarex Capital

BioConnectionbioconnection.euin

BioConnection is a contract manufacturing organization (CMO) providing aseptic fill & finish services and freeze-drying (lyophilization) for sterile pharmaceutical drug products at clinical and commercial scale.

Advanced ManufacturingBiotechMedical Devices

Co-investorsBOM

ERS
Imcheckimchecktherapeutics.cominacquired by Clementia

ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation.

BiotechHealthtech

Co-investorsAndera PartnersKurma PartnersPfizer Venture InvestmentsPureos BioventuresAgent Capital

Kinaset Therapeuticskinasettherapeutics.comin𝕏Jan 2026

Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.

BiotechHealthtechMedfield, US

Roger Heerman(Chief Business/Operating Officer / Co-Founder)Frazer Morgan(Chief Development Officer / Co-Founder)Robert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)

BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)

Co-investors5AM VenturesAtlas VentureRA CapitalEQT Life SciencesSixty Degree CapitalVivo Capital+1 more

Smart Battery Solutionssmart-battery-solutions.dein

SBS (Smart Battery Solutions) is a German manufacturer that develops, produces, and services lithium-ion batteries, covering the full product life cycle for various industries and applications such as warehouse robotics, industrial drones, rehab technology, light mobility, e-scooters, e-watercraft, e-bikes, and e-cargo.

EnergyHardwareMobility & Transportation

SMG
Spineartspineart.comin

SpineArt develops medical solutions focused on spinal care, emphasizing quality, innovation, and simplicity in their offerings.

Medical Devices

Variotech

Exits · 1

IPOs and acquisitions across the tracked portfolio

Imcheckacq. by Clementia

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Gimv made?
Gimv has 5 tracked investments.
What stage does Gimv invest at?
Gimv invests at the Growth, Late Stage stages.
What is Gimv's typical check size?
Gimv typically writes checks of $21M – $430M.
What sectors does Gimv focus on?
Gimv focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Consumer, Data & Infrastructure, Energy, FoodTech, Hardware, Healthtech, Medical Devices, New Materials, SaaS, Semiconductors, Wellness & Fitness.
Where is Gimv located?
Gimv is headquartered in Antwerp, BE.
Does Gimv lead rounds?
Yes, Gimv leads investment rounds.

Images

Gimv photoGimv photoGimv photoGimv photo

Similar investors

Featured in lists